Tenerife, Baby Boy E.
HRN: 22-13-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
11/02/2022
11/08/2022
IV
15
OD
Neonatal Sepsi
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes